Free Trial
→ Tech funds are hemorrhaging cash: Sell this stock now (From Chaikin Analytics) (Ad)

20 Stocks Wall Street Analysts Love the Most - 15 of 20

Slide 15
Back to 14
Continue to 16
 
Back to 14
Continue to 16
 

Teva Pharmaceutical Industries (NYSE:TEVA)

Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
7 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$19.67 (19.7% Upside)

About Teva Pharmaceutical Industries

Teva Pharmaceutical Industries logoTeva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
10/23/2024BarclaysBoost Price TargetOverweight ➝ Overweight$22.00 ➝ $25.00
10/21/2024JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$16.00 ➝ $18.00
9/3/2024UBS GroupBoost Price TargetBuy ➝ Buy$24.00 ➝ $26.00
8/1/2024BarclaysBoost Price TargetOverweight ➝ Overweight$21.00 ➝ $22.00
7/10/2024UBS GroupBoost Price TargetBuy ➝ Buy$22.00 ➝ $24.00
7/10/2024ArgusUpgradeHold ➝ Buy$20.00
6/27/2024Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$19.00 ➝ $23.00
6/5/2024BarclaysBoost Price TargetOverweight ➝ Overweight$20.00 ➝ $21.00
5/30/2024Bank of AmericaBoost Price TargetBuy ➝ Buy$18.00 ➝ $21.00
5/13/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$19.00 ➝ $20.00
Slide 15
Back to 14
Continue to 16
 

There is a little known company that is changing warfare (Ad)

With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t

More From MarketBeat
There is a little known company that is changing warfare
With geo - political instability around the world investors are flocking to defense contract stocks. There...
Reticulate | Sponsored
7 Oversold Stocks That Could Be Setting Up for a Rally
In 2024, investors are still wrestling with uncertainty. Will there be rate cuts, and what will they mean for ...
MarketBeat
Tech funds are hemorrhaging cash: Sell this stock now
Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...
Chaikin Analytics | Sponsored
15 Healthcare Stocks that Analysts Love in a Post-Pandemic World
There are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutica...
MarketBeat
5 Stocks that could triple in a week
Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...
Traders Agency | Sponsored
The 7 Best Electric Vehicle Stocks That Aren't Tesla
We all know that electric vehicles are the future of day-to-day transportation. They are simpler to manufactur...
MarketBeat